The impact of histologic tumor response on survival of patients treated with neoadjuvant mFOLFOX6 plus bevacizumab for the synchronous liver metastases from colorectal cancer.

被引：3
|
作者：
Katayose, Yu
Ishida, Kazuyuki
Nakagawa, Kei
Yamauchi, Junichiro
Oikawa, Masaya
Sakurai, Naoki
Musha, Hiroaki
Shimamura, Hiromune
Miura, Koh
Motoi, Fuyuhiko
Egawa, Shinichi
Unno, Michiaki
机构：
[1] Tohoku Univ, Grad Sch Med, Div Integrated Surg & Oncol, Sendai, Miyagi 980, Japan
[2] Iwate Med Univ, Dept Mol Diagnosit Pathol, Morioka, Iwate 020, Japan
[3] Sendai Kousei Hosp, Sendai, Miyagi, Japan
[4] Sendai Open Hosp, Sendai, Miyagi, Japan
[5] Yamagata Prefectural Cent Hosp, Yamagata, Japan
[6] Tohoku Rosai Hosp, Sendai, Miyagi, Japan
[7] Sendai Med Ctr, Sendai, Miyagi, Japan
[8] Tohoku Univ, Grad Sch Med, Div Hepatobiliary & Pancreat Surg, Sendai, Miyagi 980, Japan
[9] Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi 980, Japan
[10] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan
[11] Tohoku Univ, Sch Med, Sendai, Miyagi 980, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
625
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients
    Machida, Nozomu
    Yoshizaki, Kouji
    Boku, Narikazu
    Yamazaki, Kentaro
    Onozawa, Yusuke
    Fukutomi, Akira
    Yasui, Hirofumi
    Taku, Keisei
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (02) : 279 - 284
  • [42] Feasibility of mFOLFOX6 as the adjuvant treatment after curative resection of metastases from colorectal cancer in Japanese patients
    Nozomu Machida
    Kouji Yoshizaki
    Narikazu Boku
    Kentaro Yamazaki
    Yusuke Onozawa
    Akira Fukutomi
    Hirofumi Yasui
    Keisei Taku
    International Journal of Clinical Oncology, 2013, 18 : 279 - 284
  • [43] Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial
    Gruenberger, T.
    Bridgewater, J.
    Chau, I.
    Garcia Alfonso, P.
    Rivoire, M.
    Mudan, S.
    Lasserre, S.
    Hermann, F.
    Waterkamp, D.
    Adam, R.
    ANNALS OF ONCOLOGY, 2015, 26 (04) : 702 - 708
  • [44] Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial
    Leitner, Harald
    TUMORBOARD, 2015, 4 (01): : 16 - 17
  • [45] mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival
    Masamichi Yasuno
    Hiroyuki Uetake
    Megumi Ishiguro
    Nobuyuki Mizunuma
    Takamichi Komori
    Go Miyata
    Akio Shiomi
    Tatsuo Kagimura
    Kenichi Sugihara
    International Journal of Clinical Oncology, 2019, 24 : 516 - 525
  • [46] Durvalumab plus monalizumab, mFOLFOX6, and bevacizumab in patients (pts) with metastatic microsatellite-stable colorectal cancer (MSS-CRC)
    Cho, M.
    Bendell, J. C.
    Han, S-W.
    Naidoo, J.
    Lieu, C.
    Carneiro, B. A.
    Varga, E.
    Li, X.
    Kourtesis, P.
    Abdullah, S. E.
    Patel, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [47] Reply: Comment on ‘Histopathologic evaluation of liver metastases from colorectal cancer patients treated with FOLFOXIRI plus bevacizumab’
    M Schirripa
    F Loupakis
    L Pollina
    C Cremolini
    G Pasquini
    A Falcone
    British Journal of Cancer, 2013, 109 : 3129 - 3130
  • [48] Reply: Comment on 'Histopathologic evaluation of liver metastases from colorectal cancer patients treated with FOLFOXIRI plus bevacizumab'
    Schirripa, M.
    Loupakis, F.
    Pollina, L.
    Cremolini, C.
    Pasquini, G.
    Falcone, A.
    BRITISH JOURNAL OF CANCER, 2013, 109 (12) : 3129 - 3130
  • [49] Impact of perineural invasion on the outcome of patients with synchronous colorectal liver metastases treated with neoadjuvant chemotherapy and surgery
    Zozaya, Gabriel
    Alvarez Cienfuegos, Javier
    Marti-Cruchaga, Pablo
    Luis Hernandez-Lizoain, Jose
    Baixauli, Jorge
    Pardo, Fernando
    Robledano, Ramon
    Rodriguez, Javier
    Arbea, Leire
    Rotellar, Fernando
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (08): : 2523 - 2531
  • [50] Impact of perineural invasion on the outcome of patients with synchronous colorectal liver metastases treated with neoadjuvant chemotherapy and surgery
    Gabriel Zozaya
    Javier Álvarez Cienfuegos
    Pablo Martí-Cruchaga
    José Luis Hernández-Lizoain
    Jorge Baixauli
    Fernando Pardo
    Ramón Robledano
    Javier Rodríguez
    Leire Arbea
    Fernando Rotellar
    Clinical and Translational Oncology, 2023, 25 : 2523 - 2531
12345